Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, 1400 Pressler, FCT 19.5066, Unit 1489, Houston, TX 77030-4009, USA.
Thorac Surg Clin. 2013 Aug;23(3):327-35. doi: 10.1016/j.thorsurg.2013.04.007. Epub 2013 Jun 4.
Patients with N2 non-small cell lung carcinoma have ipsilateral mediastinal adenopathy with stage IIIA disease. Most of these patients are still staged solely using imaging techniques, which causes a significant error in staging if not combined with some form of surgical staging of the mediastinum. N2 disease forms a spectrum of disease ranging from occult microscopic disease to bulky multistation adenopathy. Proper understanding of the prognosis and treatment implications for each form of mediastinal lymph node metastases has led to the selective use of surgery to treat these patients. This article reviews the role of surgery in the management of patients with N2 mediastinal involvement.
N2 期非小细胞肺癌患者同侧纵隔淋巴结转移,属于 IIIA 期疾病。这些患者大多数仅依靠影像学技术分期,如果不结合纵隔某种形式的外科分期,分期错误率很高。N2 期疾病是一种从隐匿性微转移到多站肿大淋巴结转移的疾病谱。对每种纵隔淋巴结转移形式的预后和治疗意义的正确理解,导致了选择性手术治疗这些患者。本文回顾了手术在 N2 期纵隔受累患者治疗中的作用。